GAMMA Investing LLC Has $11.94 Million Position in Teleflex Incorporated (NYSE:TFX)

GAMMA Investing LLC grew its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 10,764.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 86,369 shares of the medical technology company's stock after purchasing an additional 85,574 shares during the quarter. GAMMA Investing LLC owned about 0.19% of Teleflex worth $11,935,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. grew its position in Teleflex by 4.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after buying an additional 261,279 shares in the last quarter. Geode Capital Management LLC grew its position in Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after buying an additional 8,307 shares in the last quarter. Cooke & Bieler LP grew its position in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock worth $191,962,000 after buying an additional 195,150 shares in the last quarter. Invesco Ltd. grew its position in Teleflex by 48.1% during the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock worth $190,188,000 after buying an additional 347,003 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Teleflex by 38.1% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock worth $105,102,000 after buying an additional 162,950 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Up 0.2%

NYSE TFX opened at $122.68 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock's 50 day moving average is $127.86 and its two-hundred day moving average is $155.04. The company has a market capitalization of $5.42 billion, a price-to-earnings ratio of 24.39, a PEG ratio of 1.73 and a beta of 1.10. Teleflex Incorporated has a 1-year low of $118.70 and a 1-year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. During the same quarter in the previous year, the company posted $3.21 earnings per share. Teleflex's quarterly revenue was down 5.0% compared to the same quarter last year. Equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date is Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is currently 42.90%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on TFX shares. Royal Bank of Canada decreased their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research report on Friday, May 2nd. Piper Sandler reissued a "neutral" rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Wells Fargo & Company decreased their target price on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, May 2nd. Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Teleflex has a consensus rating of "Hold" and a consensus target price of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.